Publication:
A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines

Thumbnail Image

Date

2005

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

BMJ PUBLISHING GROUP

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

PLACEBO-CONTROLLED TRIAL, INFLIXIMAB, ARTHRITIS, EFFICACY, AGENTS, SAFETY

Citation

URI

https://hdl.handle.net/11424/263643

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By